Back to Markets
PRProQR Therapeutics NV

ProQR Therapeutics NV

PRQRNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$1.58

+0.0100 (+0.64%)

As of 05/29/26 EDT · USD

Compare
Low: $1.33Current: $1.58High: $3.10

Key Statistics

Open

$1.57

Day High

$1.63

Day Low

$1.54

Prev. Close

$1.57

VolumeShares traded today.

684.30K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$166.47M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-3.17

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$3.10

52W LowLowest price over the past 52 weeks.

$1.33

50D MAAverage closing price over the last 50 trading days.

$1.64

200D MAAverage closing price over the last 200 trading days.

$1.96

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+9.7%

1M

+2.6%

6M

-26.5%

YTD

-20.6%

1Y

-4.8%

About

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer (CEO) Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.

www.proqr.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade PRQR

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.